MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijchp.2023.100367

Медицинская библиотека · International journal of clinical and health psychology : IJCHP · 2023

Non-pharmacological treatment-related changes of molecular biomarkers in major depressive disorder: A systematic review and meta-analysis.

Irwin Courtney L, Coelho Patrícia S, Kluwe-Schiavon Bruno, Silva-Fernandes Anabela, Gonçalves Óscar F, Leite Jorge, Carvalho Sandra

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Major depressive disorder (MDD) is a serious mood disorder and leading cause of disability. Despite treatment advances, approximately 30% of individuals with MDD do not achieve adequate clinical response. Better understanding the biological mechanism(s) underlying clinical response to specific psychopharmacological interventions may help fine tune treatments in order to further modulate their underlying mechanisms of action. However, little is known regarding the effect of non-pharmacological treatments (NPTs) on candidate molecular biomarker levels in MDD. This review aims to identify molecular biomarkers that may elucidate NPT response for MDD.

METHODS

We performed a systematic review and a multilevel linear mixed-effects meta-analyses, and a meta-regression. Searches were performed in PubMed, Scopus, and PsycINFO in October 2020 and July 2021.

RESULTS

From 1387 retrieved articles, 17 and six studies were included in the systematic review and meta-analyses, respectively. Although there was little consensus associating molecular biomarker levels with symptomology and/or treatment response, brain metabolites accessed via molecular biomarker-focused neuroimaging techniques may provide promising information on whether an individual with MDD would respond positively to NPTs. Furthermore, non-invasive brain stimulation interventions significantly increased the expression of neurotrophic factors (NTFs) compared to sham/placebo, regardless of add-on pharmacological treatment.

CONCLUSIONS

NTFs are candidate biomarkers to fine-tune NIBS for MDD treatment.

Для цитирования: Irwin Courtney L, Coelho Patrícia S, Kluwe-Schiavon Bruno, Silva-Fernandes Anabela, Gonçalves Óscar F, Leite Jorge, Carvalho Sandra. Non-pharmacological treatment-related changes of molecular biomarkers in major depressive disorder: A systematic review and meta-analysis.. International journal of clinical and health psychology : IJCHP. 2023. DOI: 10.1016/j.ijchp.2023.100367.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.